HNN3.0
Register
Register
Register

Project cooperationUpdated on 8 December 2025

Improving the quality of life of cancer patients with innovative natural antioxidant with clinical proven activities

Chief Scientific officer at Algosource

Guérande, France

About

AlgoSource has developed a nutraceutical that is effective in improving the quality of life of cancer patients by improving their general health and decreasing their treatment side effects : PHYCOCARE®. The reduction of oncology side effects using PHYCOCARE® has been observed by several oncologists in France, on human and on animals since 2016. These empirical results have been supported by the demonstration in 2018 of the strong antioxidant activity of the product gained in the PHASE I clinical study SPIROX (double blind against placebo) on 40 subjects. On this basis, the Hospital of Nantes (France) has been convinced to sponsor a clinical study (PROPERTY), to demonstrate a 50 % reduction of Chemotherapy Induced Peripheral Neuropathy (CIPN). We propose to generalize the use of this nutraceutical coupled with other products and innovative care interventions to improve the quality of live of patients aged 65 and more through nutrition.

With already few hospitals involved in the project, we are looking for partners such as specialised food technologist for erderly people, or hospitals with a very strong expertise in nutrition for cancer.

Similar opportunities

  • Project cooperation

    Exploring collaboration opportunities

    Vanessa Fanjul Marlé

    International Project Manager at FINBA

    Oviedo, Spain

  • Project cooperation

    Calculorther

    • Consortium/Coordinator seeks Partners
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions

    Burçin Gedik

    Business Development Manager at ATN YAZILIM A.Ş.

    Ankara, Türkiye

  • Project cooperation

    Quibim: transforming medical imaging data into actionable predictions

    • Partner seeks Consortium/Coordinator
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)

    Ana Blanco Sanchez

    Director of Grants and Innovation at Quibim SL

    Valencia, Spain